MYRIAD GENETICS, INC. (MYGN) Operating cash flow 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.8MFY2025 · since FY2016: $106.2M → $1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.8M | +120.7% |
| FY2024 | -$8.7M | +92.2% |
| FY2023 | -$110.9M | -4.3% |
| FY2022 | -$106.3M | -671.5% |
| FY2021 | $18.6M | — |
| FY2019 | $60.7M | -27.5% |
| FY2018 | $83.7M | -27.8% |
| FY2017 | $115.9M | +9.1% |
| FY2016 | $106.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MYGN financial trends
MYGN RevenueMYGN Net incomeMYGN Net marginMYGN Gross profitMYGN Gross marginMYGN Operating incomeMYGN Operating marginMYGN Free cash flowMYGN Capital expendituresMYGN Return on equityMYGN Stock buybacksMYGN Dividends paidMYGN Total assetsMYGN Total liabilitiesMYGN Shareholders’ equityMYGN overview →